Scientists collect samples to unlock secrets of alcoholic liver disease
NCT ID NCT03224949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood and urine samples from 500 people with alcoholic liver disease, heavy drinkers without liver disease, and healthy non-drinkers. The goal is to create a biorepository that researchers can use to study biomarkers and improve understanding of the disease. Participants provide samples once, with no treatment involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biorepository could help researchers discover biomarkers to better diagnose and treat alcoholic liver disease.
- What could go wrong
- This is an observational study that does not test any treatment. It only collects samples for future research, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLIC CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new MRI technique could see inside the Liver's metabolism without a biopsy
- Blood test and AI could spot liver cancer early, saving lives
- Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
- Painless liver check: could a quick scan replace the needle?
- Scientists probe inflammation clues in alcoholic liver disease
- New study aims to unlock secrets of alcoholic liver disease